Katina Dorton - 15 Jul 2021 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Katina Dorton
Issuer symbol
TCRX
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
3
Filing time
15 Jul 2021, 18:13:37 UTC
Previous filing
11 Jun 2021
Next filing
03 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCRX Stock Option (right to buy) 15 Jul 2021 Voting Common Stock 48,780 $11.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest over 4 years of service following March 1, 2021, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.